Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation

Conditions:   NSCLC;   EGFR Activating Mutation;   Brain Metastases;   Leptomeningeal Metastasis Intervention:   Drug: TY-9591 Tablets Sponsor:   TYK Medicines, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials